http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2591701-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d092c923de85138e77fa4744fa73949b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60 |
| filingDate | 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2541148548bcb1436d28305881204457 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac81a1c4eec072ed109b5f1c086acd4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a498ee40a5a1953b685c429200467798 |
| publicationDate | 2016-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2591701-C2 |
| titleOfInvention | Optically active diazabicyclooctane derivative and method for production thereof |
| abstract | FIELD: pharmaceutics. n SUBSTANCE: invention relates to an optically-active diazabicyclooctane derivative represented by a formula (F), where R 1 denotes CO 2 R, CO 2 M or CONH 2 , where R denotes a methyl group, tert-butyl group, an allyl group, benzyl group or 2,5-dioxopyrrolidin-1-yl group, and M denotes a hydrogen atom, inorganic cation selected from lithium, potassium, sodium, or an organic cation, wherein organic cation is ammonium salt formed from an amine selected from cyclohexylamine; and R 2 denotes a benzyl group or an allyl group. Also invention relates to a method of producing a compound of formula (F) and intermediate compounds, to intermediate compounds, crystalline forms of compound of formula (F), as well as use of formula (F) as a pharmaceutical intermediate compound for producing β-lactamase inhibitor, and method for production thereof. n EFFECT: novel derivatives of (2S,5R)-7-oxo-1,6-diazabicyclo[3,2,1]octane-2-carboxylic acid, as well as crystalline forms thereof, useful in synthesis of β-lactamase inhibitor. n 27 cl, 16 tbl, 25 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2713400-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2713400-C9 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2795521-C2 |
| priorityDate | 2010-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 289.